Point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) for self-monitoring coagulation status in people on long-term vitamin K antagonist therapy who have atrial ...
The system is intended for properly selected trained users ≥22 years of age who have been stabilized on anticoagulation with vitamin K antagonists for ≥6 weeks. Roche is expected to launch the ...
For patients on long-term oral anticoagulation therapy, use of point-of-care devices is associated with lower rates of death and major thromboembolic events compared with laboratory determinations of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results